Highstreet Asset Management’s Pfizer PFE Stock Holding History

Highstreet Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$19.7M	Sell	531,034 -301,967	-36%	-$10.8M	0.89%	31
2019 Q3	$28.4M	Buy	833,001 +267,459	+47%	+$9.73M	1.35%	24
2019 Q2	$23.2M	Buy	565,542 +7,362	+1%	+$292K	1.12%	25
2019 Q1	$22.5M	Buy	558,180 +131,037	+31%	+$5.25M	1.29%	25
2018 Q4	$17.7M	Sell	427,143 -39,147	-8%	-$1.63M	1.12%	29
2018 Q3	$19.5M	Sell	466,290 -404,960	-46%	-$15.6M	1.08%	28
2018 Q2	$30M	Sell	871,250 -19,226	-2%	-$657K	1.8%	18
2018 Q1	$30M	Sell	890,476 -21,729	-2%	-$747K	1.96%	17
2017 Q4	$31.3M	Buy	912,205 +483,571	+113%	+$16.5M	1.85%	14
2017 Q3	$14.5M	Buy	428,634 +93,220	+28%	+$3M	1.39%	15
2017 Q2	$10.7M	Buy	335,414 +232,334	+225%	+$7.33M	1.15%	26
2017 Q1	$3.35M	Buy	103,080 +6,435	+7%	+$203K	1.12%	23
2016 Q4	$2.98M	Sell	96,645 -32,335	-25%	-$987K	1.03%	24
2016 Q3	$4.14M	Sell	128,980 -8,481	-6%	-$284K	1.42%	17
2016 Q2	$4.59M	Sell	137,461 -18,955	-12%	-$605K	1.61%	16
2016 Q1	$4.4M	Sell	156,416 -179,008	-53%	-$5.11M	1.6%	13
2015 Q4	$10.3M	Buy	335,424 +168,362	+101%	+$5.3M	2.2%	5
2015 Q3	$4.98M	Sell	167,062 -3,376	-2%	-$108K	1.64%	15
2015 Q2	$5.42M	Buy	170,438 +8,104	+5%	+$264K	1.57%	15
2015 Q1	$5.36M	Sell	162,334 -30,346	-16%	-$965K	1.6%	15
2014 Q4	$5.69M	Sell	192,680 -44,493	-19%	-$1.28M	1.42%	19
2014 Q3	$6.65M	Buy	237,173 +50,541	+27%	+$1.42M	1.43%	17
2014 Q2	$5.25M	Sell	186,632 -80,999	-30%	-$2.31M	1.15%	25
2014 Q1	$8.16M	Sell	267,631 -22,821	-8%	-$680K	1.8%	12
2013 Q4	$8.44M	Sell	290,452 -51,013	-15%	-$1.48M	1.78%	13
2013 Q3	$9.3M	Buy	341,465 +2,792	+0.8%	+$76K	1.94%	11
2013 Q2	$9M	Buy	+338,673	New	+$9.36M	1.91%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Highstreet Asset Management's PFE Position: Q4 2019 in Review

Highstreet Asset Management reduced its Pfizer (PFE) stake by 36% in Q4 2019, selling an estimated $10.8M and leaving 531,034 shares worth $19.7M. The position accounts for 0.89% of the portfolio, ranked #31.

Highstreet Asset Management first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $31.3M in Q4 2017. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

Highstreet Asset Management held 531,034 shares of Pfizer worth $19.7M as of Q4 2019.
Highstreet Asset Management sold 301,967 Pfizer shares in Q4 2019, an estimated $10.8M.
Pfizer made up 0.89% of Highstreet Asset Management's portfolio in Q4 2019, its #31 holding.
Highstreet Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
Highstreet Asset Management's Pfizer position peaked at $31.3M in Q4 2017.
2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.